Previous studies have illustrated that the globulin-to-prealbumin ratio predicted the 3-month functional outcome in patients with AIS receiving rt-PA therapy (Li et al., 2022); however, they did not demonstrate the predictive power of globulin level as a single indicator. The gene discussed is TTR; the disease is androgen insensitivity syndrome.